Page last updated: 2024-09-04

n(4)-octadecyl-1-arabinofuranosylcytosine and African Lymphoma

n(4)-octadecyl-1-arabinofuranosylcytosine has been researched along with African Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koller-Lucae, SK; Schott, H; Schwendener, RA1

Other Studies

1 other study(ies) available for n(4)-octadecyl-1-arabinofuranosylcytosine and African Lymphoma

ArticleYear
Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
    British journal of cancer, 1999, Volume: 80, Issue:10

    Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Cytarabine; Drug Carriers; Endocytosis; Hot Temperature; Humans; Lipoproteins, LDL; Liposomes; Protein Binding; Receptors, LDL; Tumor Cells, Cultured

1999